110 related articles for article (PubMed ID: 16952362)
1. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients.
Ronga M; Baldo F; Zappalà G; Cherubino P;
Injury; 2006 Sep; 37 Suppl 3():S51-6. PubMed ID: 16952362
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
3. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
Calori GM; Tagliabue L; Gala L; d'Imporzano M; Peretti G; Albisetti W
Injury; 2008 Dec; 39(12):1391-402. PubMed ID: 19027898
[TBL] [Abstract][Full Text] [Related]
4. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
[TBL] [Abstract][Full Text] [Related]
5. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results.
Calori GM; D'Avino M; Tagliabue L; Albisetti W; d'Imporzano M; Peretti G
Injury; 2006 Sep; 37 Suppl 3():S43-50. PubMed ID: 16963360
[TBL] [Abstract][Full Text] [Related]
6. External fixation of tibial pilon fractures and fracture healing.
Ristiniemi J
Acta Orthop Suppl; 2007 Jun; 78(326):3, 5-34. PubMed ID: 17465283
[TBL] [Abstract][Full Text] [Related]
7. The role of bone morphogenetic protein-7 (Osteogenic Protein-1) in the treatment of tibial fracture non-unions. An overview of the use in Belgium.
Desmyter S; Goubau Y; Benahmed N; de Wever A; Verdonk R
Acta Orthop Belg; 2008 Aug; 74(4):534-7. PubMed ID: 18811040
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
9. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery.
Nordsletten L
Curr Med Res Opin; 2006; 22 Suppl 1():S13-7; S23. PubMed ID: 16882365
[TBL] [Abstract][Full Text] [Related]
11. Improved healing efficacy in canine ulnar segmental defects with increasing recombinant human bone morphogenetic protein-2/allograft ratios.
Jones CB; Sabatino CT; Badura JM; Sietsema DL; Marotta JS
J Orthop Trauma; 2008 Sep; 22(8):550-9. PubMed ID: 18758287
[TBL] [Abstract][Full Text] [Related]
12. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion.
Buttermann GR
Spine J; 2008; 8(3):426-35. PubMed ID: 17977799
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?
Szpalski M; Gunzburg R
Acta Orthop Belg; 2005 Apr; 71(2):133-48. PubMed ID: 16152845
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of BMP-7: the UK perspective.
Giannoudis PV; Tzioupis C
Injury; 2005 Nov; 36 Suppl 3():S47-50. PubMed ID: 16188550
[TBL] [Abstract][Full Text] [Related]
15. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human bone morphogenetic proteins in the treatment of fractures.
Kain MS; Einhorn TA
Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
[TBL] [Abstract][Full Text] [Related]
18. Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2.
O'Shaughnessy BA; Kuklo TR; Ondra SL
Spine (Phila Pa 1976); 2008 Mar; 33(5):E132-9. PubMed ID: 18317180
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of bone morphogenetic protein-2 in mature adults: posterolateral non-instrument-assisted lumbar decompression and fusion.
Hamilton DK; Jones-Quaidoo SM; Sansur C; Shaffrey CI; Oskouian R; Jane JA
Surg Neurol; 2008 May; 69(5):457-61; discussion 461-2. PubMed ID: 18207557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
